Bodycote plc (LON:BOY)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 1.61B +49.3% |
| Revenue (ttm) | 739.30M +1.7% |
| Net Income | 58.20M +104.9% |
| EPS | 0.34 +114.5% |
| Shares Out | 168.56M |
| PE Ratio | 28.37 |
| Forward PE | 17.85 |
| Dividend | 0.23 (2.42%) |
| Ex-Dividend Date | Oct 1, 2026 |
| Volume | n/a |
| Open | 952.50 |
| Previous Close | 952.50 |
| Day's Range | 948.50 - 952.50 |
| 52-Week Range | 585.00 - 958.00 |
| Beta | 1.35 |
| Analysts | Strong Buy |
| Price Target | 922.00 (-2.79%) |
| Earnings Date | Oct 27, 2026 |
About Bodycote
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in Specialist Technologies and Precision Heat Treatment divisions. The company offers heat treatment services, including altering the microstructure of metals and alloys, which include steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and furnace/vacuum brazing; and hot... [Read more]
Financial Performance
In 2025, Bodycote's revenue was 727.10 million, a decrease of -3.96% compared to the previous year's 757.10 million. Earnings were 54.90 million, an increase of 174.50%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for BOY stock is "Strong Buy." The 12-month stock price target is 922p, which is a decrease of -2.79% from the latest price.
News
Bodycote downgraded to Hold from Buy at Berenberg
Berenberg downgraded Bodycote (BYPLF) to Hold from Buy with a price target of 933 GBp, up from 900 GBp. The firm cites the company’s bid activity for the downgrade. Published…
Private equity’s London takeover spree goes on – and the politicians ignore it
The latest swoop – for Bodycote, another FTSE 250 industrial firm – has barely raised barely an eyebrow in Westminster
London Stock Exchange to lose three more firms after takeover offers
Latest purchases take value of deals to leave capital’s stock market this year past $100bn Three more London-listed companies are set to be taken over as the value of deals removing firms from the cap...
Bodycote Agrees to £1.84 Billion Acquisition by Veritas
Bodycote Agrees to £1.84 Billion Acquisition by Veritas
Veritas Capital wins race for UK's Bodycote with $2.5 billion offer
U.S.-based private equity firm Veritas Capital agreed on Tuesday to buy Britain's Bodycote in a £1.85 billion ($2.51 billion) debt-inclusive deal, outbidding CVC in a contest that also saw Apollo Glob...
FTSE 350 Broker Tips: easyJet, Next, Bodycote, L&G, Persimmon
Broker tips for UK stocks that have caught our eye over the last week include easyJet, Next, Bodycote, L&G and Persimmon
Bodycote price target raised to 950 GBp from 750 GBp at RBC Capital
RBC Capital raised the firm’s price target on Bodycote (BYPLF) to 950 GBp from 750 GBp and keeps a Sector Perform rating on the shares.
Private equity circles industrial coatings business Bodycote with a double takeover swoop
Bodycote has been valued at around £1.6bn by both CVC and Veritas, with the board 'minded to recommend' each should they result in a firm offer.
Bodycote Receives Takeover Proposals From CVC And Veritas
(RTTNews) - Bodycote Plc (BOY.L) on Wednesday said it has received two separate conditional cash takeover proposals from private equity firms CVC Advisers and Veritas Capital for the entire company.
UK's Bodycote gets possible cash offers from CVC and Veritas
Bodycote said on Wednesday it had received separate takeover proposals from private equity firms CVC Advisers and Veritas Capital, valuing the thermal processing services provider at about £1.56 billi...
Bodycote H1 Earnings Call Highlights
Bodycote LON: BOY reported first-half core organic revenue growth of 9.6%, supported by strong demand in aerospace and defense, industrial gas turbines (IGT), medical and semiconductor-related markets...
Bodycote Earnings Call Transcript: H1 2026
Strong first-half results driven by nearly 10% core organic revenue growth, led by Aerospace & Defense, IGT, and Medical, offsetting automotive weakness. Margins and EPS improved, with continued benefits from the Optimise program and a robust M&A pipeline supporting future growth.
Bodycote Quarterly report: H1 2026
Bodycote has published its H1 2026 quarterly earnings report on July 28, 2026.
Bodycote Slides: H1 2026
Bodycote has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 28, 2026.
Bodycote reinstated with a Sector Perform at RBC Capital
RBC Capital reinstated coverage of Bodycote (BYPLF) with a Sector Perform rating and 750 GBp price target The firm says bid interest from Apollo was short-lived. Bodycote would not be…
Bodycote reinstated with an Overweight at Barclays
Barclays reinstated coverage of Bodycote (BYPLF) with an Overweight rating and 820 GBp price target following Apollo’s confirmation that it does not intend to make a firm offer for the…
Bodycote price target raised to 960 GBp from 835 GBp at Deutsche Bank
Deutsche Bank analyst Thomas Elgar raised the firm’s price target on Bodycote (BYPLF) to 960 GBp from 835 GBp and keeps a Buy rating on the shares. Published first on…
Bodycote Earnings release: Trading update
Bodycote released its earnings on May 27, 2026, summarizing the period's financial results.
Bodycote price target lowered to 905 GBp from 920 GBp at Jefferies
Jefferies analyst Andy Douglas lowered the firm’s price target on Bodycote (BYPLF) to 905 GBp from 920 GBp and keeps a Buy rating on the shares. FY25 preliminary results were…
Bodycote price target raised to 700 GBp from 670 GBp at JPMorgan
JPMorgan raised the firm’s price target on Bodycote (BYPLF) to 700 GBp from 670 GBp and keeps a Neutral rating on the shares.
Bodycote downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Bodycote (BYPLF) to Sector Perform from Outperform with an unchanged price target of 775 GBp. The firm cites valuation for the downgrade.
Bodycote Earnings Call Transcript: H2 2025
Stable core revenues in 2025 with strong H2 momentum in Aerospace & Defense, while oil and gas and auto markets remained weak. Margin and EPS declined, but cash conversion and balance sheet stayed robust. 2026 outlook is for organic growth and margin expansion, led by aerospace and IGT.
Bodycote Annual report: H2 2025
Bodycote has published its H2 2025 annual report on March 11, 2026.
Bodycote Slides: H2 2025
Bodycote has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 11, 2026.
Bodycote Annual report: H2 2025
Bodycote has published its H2 2025 annual report on March 11, 2026.